Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamictal in Acute Bipolar Depression
NCT00056277Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Lamotrigine with Placebo (2 arms). Primary endpoint: Montgomery-Asberg Depression Rating Scale at 8 weeks. Started Feb 2003; status: completed.
02
Drugs
lamotrigine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00056277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056277.